公开(公告)号：US10968178B2

公开(公告)日：2021-04-06

申请号：US16496530

申请日：2018-03-29

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Yoshito Terao ,  Masashi Takahashi ,  Ryoma Hara ,  Kousuke Hidaka ,  Hideki Furukawa ,  Takeshi Yamasaki ,  Shizuo Kasai

IPC: C07D209/96 ,  C07D401/12 ,  C07D403/12 ,  C07D471/10 ,  C07D491/052 ,  A61P3/10 ,  A61P9/04

Abstract: The present invention aims to provide a heterocyclic compound having an IP6K inhibitory action and expected to be useful as a prophylactic or therapeutic agent for—diseases such as cardiac failure, diabetes and the like. A compound represented by the formula (I): wherein each symbol is as defined in the SPECIFICATION, or a salt thereof has an IP6K inhibitory action and is expected to be useful as a prophylactic or therapeutic agent for diseases such as cardiac failure, diabetes and the like.